BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 27, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Feb. 4, 2021

Feb. 4, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Active, Angelini, Angiotensin, Arvelle, Astrazeneca, Beximco, BMS, BNC, Connectyx, Diamond, Evotec, Famar, Gensight, Golden, Molecular Partners, Neogenomics, Novartis, Novavax, Serum Institute, Sio, Sunshine, Wuxi.
Read More

In the clinic for Feb. 4, 2021

Feb. 4, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Agenus, Aldeyra, Aligos, Atea, Biogen, Botanix, Calliditas, Codiak, Corvus, Crinetics, Curevac, Dynavax, Eucure, Gilead, Golden, I-Mab, Innocare, Neurorx, Reistone, Surface Ophthalmology.
Read More

Financings for Feb. 4, 2021

Feb. 4, 2021
Biopharmas raising money in public or private financings, including: Bioventus, Cybin, Durect, Equillium, Inivata, Iterum, Kaleido, Revolution, Rhythm, Tyme, Utility, V-Bio, Veracyte.
Read More

Earnings for Feb. 4, 2021

Feb. 4, 2021
Quarterly snapshots from biopharma companies with marketed products, including: Acceleron, Alexion.
Read More

Appointments and advancements for Feb. 4, 2021

Feb. 4, 2021
New hires and promotions in the biopharma industry, including: Catamaran, Codexis, Inozyme, Merck, Microbiotica, Nkmax, Pepgen, Secarna, TCR².
Read More

Regulatory actions for Feb. 1, 2021

Feb. 4, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamas, Amgen, Applied, Argenx, Biogen, Janssen, Jeil, Merck, Mirum, Rockwell, Vyne, Zosano.
Read More

Regulatory front for Feb. 3, 2021

Feb. 3, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Task force gives CAS screening another thumbs down; USPTO expands program with Japan’s, South Korea’s patent offices; Boston Sci recalls electrode for ICD due to risk of fracture; CDSCO posts lists of approved tests.
Read More

Regulatory actions for Feb. 3, 2021

Feb. 3, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Clew, Pulse Biosciences.
Read More

Other news to note for Feb. 3, 2021

Feb. 3, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ardent Health Services, Ams, Axim Biotech, Bendcare, Botanisol Analytics, Casenet, Centene, Color, Colossal Contracting, Congenica, Decipher, Epredia, Extra Horizon, Fujifilm, Gabriel Precision Oncology, Gpm, Histosonics, Inspiremd, McGinley Orthopedics, Medline, Meridian Bioscience, Mobile Heartbeat, Netsmart, New England Biolabs, Ocean Insight, Quantumdx, Veeva, Veracyte, Vizient, Zyter.
Read More

In the clinic for Feb. 3, 2021

Feb. 3, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arquer Diagnostics, Diadem, Nēsos.
Read More
Previous 1 2 … 1385 1386 1387 1388 1389 1390 1391 1392 1393 … 1759 1760 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • 3D rendering of skin cells and elastin with collagen layer

    First-in-class pan-inflammasome blocker for hidradenitis suppurativa

    BioWorld Science
    Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld
    Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
  • Illustration of cancer cell in crosshairs being destroyed

    RX-10616 improves radiotherapy efficacy in HNSCC

    BioWorld Science
    Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing